Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Barbara G. Littlefield resigned from the Board of Directors of American Superconductor Corporation, effective September 18, 2026. The resignation was disclosed under Item 5.02 of the company's 8-K filing.
Real Remax Group Insider David L. Liniger Sells $1.01M of Stock
David L. Liniger sold 52,876 shares of Real Remax Group Inc. at $19.12 a share, worth $1.01M in total on Sep 17, 2026. Shares held after the trade: 5,539,905 (-0.9%).
Bridger Aerospace Group Holdings Leadership Change
Bridger Aerospace Group Holdings, Inc. appointed Rebecca Gerleman as Senior Vice President and Chief Accounting Officer, effective September 18, 2026. Ms. Gerleman previously served as the company's Senior Director of Technical Accounting & Financial Reporting and spent twelve years at Deloitte & Touche LLP prior to joining the firm.
Graham Purdy has resigned as President, CEO, and board member of Turning Point Brands for personal reasons, effective September 30, 2026. The company's Board of Directors has appointed current Executive Chairman David E. Glazek to succeed him as CEO, effective October 1, 2026.
PDS Biotechnology Corporation filed an updated corporate presentation deck as an exhibit to its 8-K. The presentation provides an overview of the company's oncology drug development programs, including PDS0101 and PDS0301, as of September 2026. This filing serves as a strategic update for investors regarding the company's clinical trial pipeline and research collaborations.
Lantheus Holdings M&A Deal with Curium US Holdings LLC
Lantheus Holdings provided a regulatory update on its pending merger with Curium US Holdings LLC, noting that Curium voluntarily withdrew and refiled its HSR Act pre-merger notification to provide the FTC with additional time for review. The new 30-day waiting period is set to expire on October 21, 2026, and the parties still expect to close the transaction in the first half of 2027.
Insight Molecular Diagnostics M&A Deal with Chronix Biomedical, Inc.
Insight Molecular Diagnostics (iMDx) entered into Amendment No. 2 to its merger agreement with Chronix, modifying the earnout structure related to the CNI Monitor technology. The amendment establishes that equity holders will receive a 10% royalty on sales until a potential sale of the technology occurs, at which point they will receive a final payment of 10% of the gross sale proceeds.
DSS, Inc. entered into a securities purchase agreement with related party Alset Inc., receiving a $500,000 loan in exchange for a convertible promissory note and warrants for 8,000,000 shares. The note bears 3% interest and is convertible into common stock at $0.50 per share, while the warrants have an exercise price of $0.55 per share.
CDW $1.5B Debt Financing with U.S. Bank Trust Company, National Association
CDW Corporation completed a registered offering of $1.5 billion in senior notes across three tranches: $600 million due 2029, $500 million due 2032, and $400 million due 2033. The notes are fully and unconditionally guaranteed by CDW Corporation on an unsecured senior basis and were issued under a base indenture with supplemental indentures.
Techprecision $4.5M Debt Financing with Beacon Bank & Trust
TechPrecision's subsidiary, Ranor, Inc., entered into a fifteenth amendment to its loan agreement with Beacon Bank & Trust. The amendment extends the maturity date of the company's $4.5 million revolving line of credit from September 15, 2026, to October 16, 2026.
Twist Bioscience CEO Emily M. Leproust Sells $56.3M of Stock
Emily M. Leproust, CEO, sold 356,546 shares of Twist Bioscience Corp at $151.46 to $163.39 a share (average $157.99) in 13 transactions, worth $56.3M in total on Sep 17, 2026. Shares held after the trade: 673,569 (-25.6%).
DoorDash Chief Business Officer Keith Yandell Sells $438K of Stock
Keith Yandell, Chief Business Officer, sold 2,184 shares of DoorDash, Inc. at $200.76 a share, worth $438K in total on Sep 17, 2026. Shares held after the trade: 120,688 (-1.8%).
Hershey Insider Hershey Trust Co Trustee in Trust for Milton Hershey School Sells $3.38M of Stock
Hershey Trust Co Trustee in Trust for Milton Hershey School sold 20,000 shares of Hershey Co at $166.77 to $171.34 a share (average $169.08) in 9 transactions, worth $3.38M in total between Sep 17, 2026 and Sep 18, 2026. Shares held after the trade: 766,119 (-0.1%).
Resources Connection, Inc. appointed Trisha Jenks as Chief Accounting Officer and principal accounting officer, effective October 3, 2026. Ms. Jenks, who currently serves as the company's SVP and Corporate Controller, succeeds Jennifer Ryu in the principal accounting officer role following Ryu's previously announced resignation. In connection with the appointment, Ms. Jenks' annual base salary will increase to $350,000 with a guaranteed $150,000 target bonus for fiscal 2027.
Credit Acceptance $500M Debt Financing with Wells Fargo Bank, National Association
Credit Acceptance Corporation extended two credit facilities with Wells Fargo, including a $500.0 million asset-backed financing (Term ABS 2019-2) and a $500.0 million revolving secured warehouse facility. The amendments extend the revolving periods for both facilities to September 15, 2028, while adjusting interest rates to 5.83% for the Term ABS and SOFR plus 175 basis points for the warehouse facility.
Sanmina Insider Susan A. Johnson Sells $24.1K of Stock
Susan A. Johnson sold 120 shares of Sanmina Corp at $200.46 a share, worth $24.1K in total on Sep 17, 2026. Shares held after the trade: 10,123 (-1.2%).
Electra Therapeutics closed its initial public offering (IPO) of 23,333,334 shares of common stock at a price of $15.00 per share, generating gross proceeds of approximately $350.0 million. In connection with the closing, the company also filed its amended and restated certificate of incorporation and bylaws.
Sangamo Therapeutics completed the sale of its ST-920 (Fabry disease gene therapy) assets to PTC Therapeutics for $111 million in cash plus up to $100 million in contingent milestones. The sale was conducted via a court-supervised auction process as part of Sangamo's ongoing Chapter 11 bankruptcy proceedings. Additionally, the company's common stock is being formally delisted from Nasdaq effective September 27, 2026.
WW International, Inc. announced that Stephen J. Bye will officially begin his role as President and Chief Executive Officer on October 1, 2026. Upon his commencement, the Interim Office of the Chief Executive will be dissolved, and Felicia DellaFortuna and Jonathan Volkmann will return to their respective roles as CFO and COO.
Bloomia Holdings reported fiscal year 2026 revenue of $48.1 million and a net loss of $11.2 million, which included a $13.2 million non-cash impairment charge. The company successfully restructured its balance sheet during the year, reducing total debt by 36% to $21.7 million, while facing operational headwinds from increased bulb costs and production waste.
Term
FY2026
“This fiscal year reminded us that we are, first and foremost, an agricultural business. Unpredictable industry-wide growing difficulties had an outsized negative impact on our margin this year. Despite these external challenges, our underlying business demonstrated significant resilience, in no small part because of the exceptional extra effort and focus the operating team gave in responding to these difficulties and resulting unprecedented waste.”
Mark Jundt, Chairman and Co-Chief Executive Officer
“Additionally, we believe that the short-term financial impact of the waste issue, while significant, will be overshadowed by our big win for the year: thanks to the support and confidence of our stockholders, the Company was able to successfully complete a capital raise that retired over $19 million of debt obligations for approximately $12 million in consideration.”
Mark Jundt, Chairman and Co-Chief Executive Officer
Clara Nagy McBane resigned from the Board of Directors effective September 18, 2026, following the satisfaction of contingencies regarding equity treatment and indemnification. Benjamin Rosenzweig was appointed to the Board to fill the vacancy and will serve on the Compensation Committee, while Shawn Kravetz was appointed to the Audit Committee. In connection with these changes, the Board accelerated the vesting of 93,678 RSUs for Ms. McBane and granted Mr. Rosenzweig $225,000 worth of RSUs.
Pharvaris Director Elisabeth Bjork Sells $1.99M of Stock
Elisabeth Bjork, Director, sold 52,500 shares of Pharvaris N.V. at $37.89 a share, worth $1.99M in total on Sep 17, 2026. Shares held after the trade: 15,167 (-77.6%).
Pharvaris Director Robert Glassman Sells $559K of Stock
Robert Glassman, Director, sold 14,493 shares of Pharvaris N.V. at $38.56 a share, worth $559K in total on Sep 17, 2026. Shares held after the trade: 10,500 (-58.0%).
Pharvaris Chief Early Development Anne Lesage Sells $765K of Stock
Anne Lesage, Chief Early Development, sold 20,000 shares of Pharvaris N.V. at $38.27 a share, worth $765K in total on Sep 17, 2026. Shares held after the trade: 73,969 (-21.3%).
ExchangeRight Income Fund declared a monthly cash dividend of $0.1449 per share for all outstanding common share classes as of August 31, 2026. The filing also provided a routine update on its continuous private placement offering, which has raised $546.75 million to date, and its dividend reinvestment plan.
BancFirst Corporation declared a quarterly cash dividend of $0.52 per share on its common stock, payable on October 15, 2026. The company also announced a quarterly interest payment on $26.8 million of its 7.20% Junior Subordinated Debentures to fund a $0.45 per share dividend for BFC Capital Trust II preferred securities.
Barings Private Credit Corporation sold approximately 1.1 million unregistered shares of common stock for $22.0 million in a private placement. The company is conducting a continuous private offering for up to $4.5 billion, having raised over $3 billion to date.
Sajal K. Srivastava resigned as President, Chief Investment Officer, and Board member of TriplePoint Private Venture Credit Inc., effective December 31, 2026. Ian Schworer was appointed to succeed him as Chief Investment Officer, while the Board's size will be reduced from five to four members following the departure.
Sajal K. Srivastava notified the company of his intention to resign as President, Chief Investment Officer, and Board Director, effective December 31, 2026. In response, the Board appointed Ian Schworer, currently the Chief Credit Officer of TriplePoint Capital, to succeed Srivastava as Chief Investment Officer and reduced the Board size from eight to seven members.
Dave & Buster's Entertainment Executive Compensation
Dave & Buster's Entertainment, Inc. appointed Amanda Busby as Chief Operations Officer, effective August 11, 2026. Her compensation package includes a $450,000 base salary, a 70% target cash bonus, and a significant equity award consisting of 72,464 RSUs, 74,294 stock options, and 55,741 PSUs. The filing also notes the appointment of Derek Sample as Chief Accounting Officer and several other executive promotions.